Dialysis Access Treatment Devices – Market Insights – Japan

The Japanese dialysis access treatment device market will be driven by significant rise in ESRD population and will grow modestly through 2032. New product launches such as DCB, DES, and percutaneous AVFs along with the favorable clinical trials results associated with these devices are expected to positively impact the market. The impact of the COVID-19 pandemic in the short term, as well as ASP declines caused by MHLW biennial reimbursement cuts over the forecast period, will limit market revenues.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for dialysis access treatment products in Japan from 2019 through 2032.

Dialysis access creation segment is experiencing a shift in trend.

What are the upcoming developments in the dialysis access creation device market?

How are clinical developments across the globe impacting the Japanese dialysis access treatment device market?

Which competitors will benefit from these changes?

Certain segments within the dialysis access creation and maintenance spaces will fuel the growth of their respective markets in the coming years.

What are the product types and their subtypes that will exhibit relatively high growth rates over the forecast period?

What impact will recent clinical trial results for percutaneous AVF have on the dialysis access creation market?

PTA balloon catheter space is highly lucrative.

What are the market dynamic changes in the PTA balloon catheter space?

How are DCBs expected to grow in the Japanese market?

Which are the upcoming competitors in this space?